BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 35024979)

  • 1. Clinical outcomes of surgical management for rare types of progressive familial intrahepatic cholestasis: a case series.
    Masahata K; Ueno T; Bessho K; Kodama T; Tsukada R; Saka R; Tazuke Y; Miyagawa S; Okuyama H
    Surg Case Rep; 2022 Jan; 8(1):10. PubMed ID: 35024979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive Familial Intrahepatic Cholestasis: A Study in Children From a Liver Transplant Center in India.
    Mehta S; Kumar K; Bhardwaj R; Malhotra S; Goyal N; Sibal A
    J Clin Exp Hepatol; 2022; 12(2):454-460. PubMed ID: 35535061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of surgical management of familial intrahepatic cholestasis 1 and bile salt export protein deficiencies.
    Bull LN; Pawlikowska L; Strautnieks S; Jankowska I; Czubkowski P; Dodge JL; Emerick K; Wanty C; Wali S; Blanchard S; Lacaille F; Byrne JA; van Eerde AM; Kolho KL; Houwen R; Lobritto S; Hupertz V; McClean P; Mieli-Vergani G; Sokal E; Rosenthal P; Whitington PF; Pawlowska J; Thompson RJ
    Hepatol Commun; 2018 May; 2(5):515-528. PubMed ID: 29761168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive familial intrahepatic cholestasis.
    Srivastava A
    J Clin Exp Hepatol; 2014 Mar; 4(1):25-36. PubMed ID: 25755532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive Familial Intrahepatic Cholestasis (PFIC) in Indian Children: Clinical Spectrum and Outcome.
    Agarwal S; Lal BB; Rawat D; Rastogi A; Bharathy KG; Alam S
    J Clin Exp Hepatol; 2016 Sep; 6(3):203-208. PubMed ID: 27746616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune BSEP disease: disease recurrence after liver transplantation for progressive familial intrahepatic cholestasis.
    Kubitz R; Dröge C; Kluge S; Stross C; Walter N; Keitel V; Häussinger D; Stindt J
    Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):273-84. PubMed ID: 25342496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes after cholecystocolostomy for progressive familial intrahepatic cholestasis.
    Chen L; Xiao H; Ren XH; Li L
    Hepatol Res; 2018 Dec; 48(13):1163-1171. PubMed ID: 29934967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newer variants of progressive familial intrahepatic cholestasis.
    Vinayagamoorthy V; Srivastava A; Sarma MS
    World J Hepatol; 2021 Dec; 13(12):2024-2038. PubMed ID: 35070006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    Miethke AG; Moukarzel A; Porta G; Covarrubias Esquer J; Czubkowski P; Ordonez F; Mosca A; Aqul AA; Squires RH; Sokal E; D'Agostino D; Baumann U; D'Antiga L; Kasi N; Laborde N; Arikan C; Lin CH; Gilmour S; Mittal N; Chiou FK; Horslen SP; Huber WD; Jaecklin T; Nunes T; Lascau A; Longpre L; Mogul DB; Garner W; Vig P; Hupertz VF; Gonzalez-Peralta RP; Ekong U; Hartley J; Laverdure N; Ovchinsky N; Thompson RJ
    Lancet Gastroenterol Hepatol; 2024 May; ():. PubMed ID: 38723644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive familial intrahepatic cholestasis.
    Jacquemin E
    Clin Res Hepatol Gastroenterol; 2012 Sep; 36 Suppl 1():S26-35. PubMed ID: 23141890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequencing of FIC1, BSEP and MDR3 in a large cohort of patients with cholestasis revealed a high number of different genetic variants.
    Dröge C; Bonus M; Baumann U; Klindt C; Lainka E; Kathemann S; Brinkert F; Grabhorn E; Pfister ED; Wenning D; Fichtner A; Gotthardt DN; Weiss KH; McKiernan P; Puri RD; Verma IC; Kluge S; Gohlke H; Schmitt L; Kubitz R; Häussinger D; Keitel V
    J Hepatol; 2017 Dec; 67(6):1253-1264. PubMed ID: 28733223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive familial intrahepatic cholestasis.
    Davit-Spraul A; Gonzales E; Baussan C; Jacquemin E
    Orphanet J Rare Dis; 2009 Jan; 4():1. PubMed ID: 19133130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation Analysis and Disease Features at Presentation in a Multi-Center Cohort of Children With Monogenic Cholestasis.
    Hertel PM; Bull LN; Thompson RJ; Goodrich NP; Ye W; Magee JC; Squires RH; Bass LM; Heubi JE; Kim GE; Ranganathan S; Schwarz KB; Bozic MA; Horslen SP; Clifton MS; Turmelle YP; Suchy FJ; Superina RA; Wang KS; Loomes KM; Kamath BM; Sokol RJ; Shneider BL;
    J Pediatr Gastroenterol Nutr; 2021 Aug; 73(2):169-177. PubMed ID: 34016879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasobiliary drainage prior to surgical biliary diversion in progressive familial intrahepatic cholestasis type II.
    Jannone G; Stephenne X; Scheers I; Smets F; de Magnée C; Reding R; Sokal EM
    Eur J Pediatr; 2020 Oct; 179(10):1547-1552. PubMed ID: 32291498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in presentation and progression between severe FIC1 and BSEP deficiencies.
    Pawlikowska L; Strautnieks S; Jankowska I; Czubkowski P; Emerick K; Antoniou A; Wanty C; Fischler B; Jacquemin E; Wali S; Blanchard S; Nielsen IM; Bourke B; McQuaid S; Lacaille F; Byrne JA; van Eerde AM; Kolho KL; Klomp L; Houwen R; Bacchetti P; Lobritto S; Hupertz V; McClean P; Mieli-Vergani G; Shneider B; Nemeth A; Sokal E; Freimer NB; Knisely AS; Rosenthal P; Whitington PF; Pawlowska J; Thompson RJ; Bull LN
    J Hepatol; 2010 Jul; 53(1):170-8. PubMed ID: 20447715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maralixibat for the treatment of PFIC: Long-term, IBAT inhibition in an open-label, Phase 2 study.
    Loomes KM; Squires RH; Kelly D; Rajwal S; Soufi N; Lachaux A; Jankowska I; Mack C; Setchell KDR; Karthikeyan P; Kennedy C; Dorenbaum A; Desai NK; Garner W; Jaecklin T; Vig P; Miethke A; Thompson RJ
    Hepatol Commun; 2022 Sep; 6(9):2379-2390. PubMed ID: 35507739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial external biliary diversion in bile salt export pump deficiency: Association between outcome and mutation.
    Ellinger P; Stindt J; Dröge C; Sattler K; Stross C; Kluge S; Herebian D; Smits SHJ; Burdelski M; Schulz-Jürgensen S; Ballauff A; Schulte Am Esch J; Mayatepek E; Häussinger D; Kubitz R; Schmitt L
    World J Gastroenterol; 2017 Aug; 23(29):5295-5303. PubMed ID: 28839429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis.
    Jansen PL; Strautnieks SS; Jacquemin E; Hadchouel M; Sokal EM; Hooiveld GJ; Koning JH; De Jager-Krikken A; Kuipers F; Stellaard F; Bijleveld CM; Gouw A; Van Goor H; Thompson RJ; Müller M
    Gastroenterology; 1999 Dec; 117(6):1370-9. PubMed ID: 10579978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of partial internal biliary diversion on long-term outcomes in patients with progressive familial intrahepatic cholestasis: experience in 44 patients.
    Foroutan HR; Bahador A; Ghanim SM; Dehghani SM; Anbardar MH; Fattahi MR; Forooghi M; Azh O; Tadayon A; Sherafat A; Yaghoobi AA; Ashraf MA
    Pediatr Surg Int; 2020 May; 36(5):603-610. PubMed ID: 32206891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-center experience in management of progressive familial intrahepatic cholestasis.
    Varol Fİ; Selimoğlu MA; Güngör Ş; Yılmaz S; Tekedereli İ
    Arab J Gastroenterol; 2021 Dec; 22(4):310-315. PubMed ID: 34840097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.